Enter your age at diagnosis, tumor characteristics, treatment details, and hormonal/reproductive history to estimate your breast cancer local recurrence risk. The calculator returns a 5-year and 10-year recurrence risk percentage along with a risk category — helping you understand where you stand and support informed conversations with your care team. Also try the calculate Predicted Ovulation Date, Last Day of Clomid & Fertility Window Start — Clomid Ovulation.
Disclaimer: This tool is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions.
Results
Estimated 5-Year Recurrence Risk
--
Estimated 10-Year Recurrence Risk
--
Risk Category
--
Estimated Risk Reduction from Treatment
--
Estimated Recurrence Risk Over Time
Results Table
Wondering how your unique situation influences the odds of cancer returning? The breast cancer recurrence risk calculator offers a science-backed way to estimate your individual probability of recurrence or developing a new malignancy after a breast condition diagnosis. By drawing on large data sets and inputting key details about your diagnostic history, therapies, and background, this outcomes predictor gives you insight that can help guide important decisions—whether considering further therapies, weighing surgical options, or planning long-term surveillance. While no algorithm can say with certainty what will happen, knowing your calculated chance can empower you to have more informed conversations with your care team and loved ones about the next steps in your breast cancer journey.
Understanding Personalized Breast Cancer Recurrence Risk Calculator Tools
How Recurrence Calculators Work to Predict Risk
Prediction calculators—including those based on multi-institutional prediction models and endorsed by the American Joint Committee on Cancer—are designed for patients and clinicians to estimate the probability of a malignancy returning. These online estimators work by integrating factors such as:
Patient characteristics: age at diagnosis, reproductive history, personal details about the patient
Disease attributes: tumor size (e.g., <=5cm tumor), grade, lymphovascular invasion, ER/PR status, HER2 status, details about the cancer
Treatment characteristics: procedure type (such as mastectomy or breast-conserving operation), use of endocrine approaches, chemotherapy, or trastuzumab, and whether upfront mastectomy was performed
By inputting these details, calculators—such as the Gail Model (BCRAT), Predict, and other validated versions—generate an estimate over defined time intervals, such as 5 years, 10 years, or up to age 90. These estimators have been refined through further studies, using outcome data from thousands of individuals with varying factors.
For example, an online system may use this framework to provide a likelihood estimate:
Absolute probability: The chance or probability you will develop either local return, distant spread, or a new invasive malignancy within the next interval.
Relative probability: How your probability compares to a general population of similar individuals, considering your background and tumor characteristics.
Because the output is a probability (such as a 10% chance of problems within an interval), it should be interpreted as an evidence-based guide, not a forecast of precise outcomes for any single person. This is why the likely proportion of events reported should be used as an aid, not a promise. The life expectancy of similar women is used to inform these calculations and rates are continuously monitored in outcome studies. These estimators also help improve survival rates by informing discussions. You can learn more about predict methods used and how rates are assessed in validation research.
Limitations and Scope of the Breast Cancer Recurrence Risk Calculator
While current outcomes predictors are highly useful, they have limitations that must be recognized:
Validated calculators (such as the Gail Model or Predict) have been extensively tested in data sets from White, Black/African American, Hispanic, Asian, and Pacific Islander individuals, but may underestimate probability in subgroups with limited data. For example, projections may be less accurate for American Indian/Alaska Native females, or for Hispanic women born outside the United States.
People who carry BRCA1 or BRCA2 mutations, or who have a strong family history of malignancies (mother, sisters, daughters), may not be accurately represented by standard calculators. Specialized sources or genetic screening may be needed for these populations.
Some online calculators may not apply to individuals with a history of ductal carcinoma in situ, lobular carcinoma in situ, or those with previous invasive tumors.
Limited information on late distant spread and results after procedures or systemic therapies can impact accuracy, especially for long-term predictions beyond 10 or 15 after initial assessment.
Projections, while accurately calculated for many, may not allow you to know precisely who will or will not develop a repetition of illness. Some individuals with high calculated probabilities may remain free of new events, while others with lower probability face new episodes. This estimation is modeled by comparing survival of similar women.
Current research and ongoing studies continue to refine and validate these estimators, aiming for ever-more precise projections. Improving how these systems work helps enhance the overall effort to improve outcomes, offering greater hope for the future and helping to improve survival rates.
Who Should Use These Predict Breast Cancer Calculators?
These online calculators are most commonly used by:
Women recently diagnosed with early-stage disease or considering adjuvant options after an operation
Healthcare providers looking to support individuals in understanding their outlook, weighing strategies, or making decisions about endocrine options, chemotherapy, or radiation
People and their families who seek evidence-based information to help with long-term planning and follow-up care
For outcomes predictor after mastectomy with N1 breast condition, estimators often focus on those with one to three positive lymph nodes sampled and a tumor size 5cm or less. These calculators help provide the chance of local issues, distant complications, overall return, and even mortality, guiding recommendations for optimal systemic management and monitoring. To use this service, you will need to input specifics about the individual and details about the tumor so results are personalized according to standardized measures. Knowing the likely proportion of similar results in life expectancy of similar females can help inform choices. Interventions for early invasive breast cancer are a key part of determining the best post-surgical plan. People are expected to survive up to fifteen following surgery and completion of therapy, depending on individual circumstances and the combination of interventions provided. If any questions arise about your individual case or care combinations, always seek a healthcare consultation.
Further Information and Support Resources to Predict Breast Cancer Outcomes
Where to Find Reliable Information on Risk Assessment and Cancer Support
If you wish to learn more or confirm the findings of any online predictor, these trusted organizations offer in-depth, up-to-date guidance on screening, prevention, and management options:
Breast Cancer Risk Assessment Tool (BCRAT) / The Gail Model
PREDICT: Online Model for Breast Cancer Prognosis
National Cancer Institute: Breast Cancer Information
American Cancer Society: Breast Cancer
Current Clinical Trials for Breast Cancer
MD Anderson Cancer Center
Breastcancer.org
Susan G. Komen Foundation
Living Beyond Breast Cancer
Young Survival Coalition
These organizations also offer useful details about tumor characteristics, available interventions, studies, and support programs tailored to those facing a breast condition and their loved ones. Many of these organizations accept donations to further research and advocacy efforts—if you wish to donate, visit their official sites.
Support and Community Initiatives for Breast Cancer Patients and Their Families
Access to support programs and community initiatives may help you and your loved ones navigate every stage of the experience and care. These may include:
Cancer support groups and peer navigators
Counseling services and patient helplines
Charities that fund research, prevention, screening, and education (such as the Susan G. Komen Foundation and Breast Cancer Now)
Awareness and donation campaigns to help #endcancer—for example, blood donation drives or fundraising for research
Many oncology centers and health organizations also run volunteer programs and provide access to the latest standard-of-care strategies and emerging options through studies. If you are seeking emotional, financial, or informational support, don’t hesitate to reach out to these vetted organizations.
Disclaimer: Interpreting Your Breast Cancer Recurrence Risk Calculator Results
This breast cancer recurrence risk calculator is an informational online estimator only. Individuals should use it in consultation with a healthcare provider. While estimators such as PREDICT, BCRAT (Gail Model), and similar outcomes predictors have been validated for diverse groups, your individual situation may be influenced by factors not captured—including personal history and reproductive background, BRCA1 and BRCA2 mutation status, or other tumor characteristics.
Projections and estimates are based on historical data and cannot guarantee results. Never delay or disregard professional advice based on this estimator—talk with your doctors about your diagnostic workup, personal determinants, calculated chances of local or distant return, appropriate strategies for early invasive breast cancer, and recommendations for follow-up care and ongoing checkups. Options for early invasive breast cancer can be complex and often require careful planning after surgery to maximize benefit and minimize chances of another problem occurring. People are often expected to survive up to fifteen following their initial care combinations. Consulting a medical professional is always recommended for detailed, case-specific support.
Further studies are ongoing, and specialists and researchers continue to improve calculators so that individuals everywhere can benefit from accurate projections—and ultimately, improve outcomes and quality of life after a breast condition diagnosis.
What is breast cancer recurrence risk and how is it calculated?
Breast cancer recurrence risk is the probability that cancer will return after initial treatment — either in the same breast (local), in the lymph nodes (regional), or elsewhere in the body (distant/metastatic). This calculator estimates risk based on established clinical factors including tumor size, grade, lymph node status, hormone receptor type, and treatments received. It uses a weighted scoring model derived from published breast oncology research. See also our Conception Calculator.
What does hormone receptor status mean for recurrence risk?
Hormone receptor status (ER/PR positive or negative) is one of the strongest predictors of recurrence type and timing. Hormone receptor-positive (ER+/PR+) cancers tend to have a lower short-term recurrence risk but can recur years or even decades later. Triple-negative and HER2+ cancers carry a higher early recurrence risk but typically do not continue rising as steeply over 10+ years. Hormonal therapy such as tamoxifen or aromatase inhibitors significantly reduces recurrence risk in ER+ cases.
How long should I take hormonal therapy after breast cancer?
Most clinical guidelines recommend 5 to 10 years of hormonal therapy (tamoxifen or an aromatase inhibitor) for hormone receptor-positive breast cancer. Extended therapy beyond 5 years has been shown to further reduce the risk of late recurrence, particularly in women with higher-risk tumor features. Your oncologist will weigh the benefits against side effects and individual health factors to determine the optimal duration for you.
What is the Tyrer-Cuzick risk model used for breast cancer?
The Tyrer-Cuzick model is a validated statistical tool that estimates a woman's lifetime risk of developing breast cancer based on personal, hormonal, and family history factors, including BRCA mutation status. It is widely used by breast cancer clinics to determine eligibility for enhanced screening, preventive medications, or prophylactic surgery. This recurrence risk calculator draws on similar risk factor principles to estimate post-treatment recurrence probability. You might also find our Breast Cancer Risk Calculator (Gail Model) useful.
What is considered a high recurrence risk score?
Generally, a 5-year recurrence risk above 15% is considered elevated, and above 30% is considered high risk in clinical practice. However, risk thresholds vary by cancer type and clinical context. Low-risk scores (below 10%) are often associated with small, low-grade, hormone receptor-positive tumors with no lymph node involvement treated with hormonal therapy. Always discuss your specific risk score with your oncologist to interpret it in the context of your full medical history.
Does having a BRCA mutation increase recurrence risk?
A BRCA1 or BRCA2 mutation increases the risk of a new primary breast cancer in the same or opposite breast, which is distinct from true recurrence but equally important. BRCA-positive individuals also face elevated risks of ovarian cancer. If you carry a BRCA mutation, your care team may recommend more aggressive surveillance, extended preventive therapy, or consideration of risk-reducing surgery such as prophylactic mastectomy.
If I am adopted or lack family history information, how do I use this calculator?
If your family history is unknown, select 'No' for first-degree relative history and 'Not Tested / Unknown' for BRCA status. The calculator will estimate your risk based on your personal clinical factors alone. While this may slightly underestimate risk if there is an unknown hereditary component, your tumor characteristics and treatment details remain the dominant drivers of recurrence risk in this model.
Can this calculator replace advice from my oncologist?
No — this tool is for educational and informational purposes only. It provides a general risk estimate based on population-level data and simplified inputs, and cannot account for all individual variables such as specific genetic panel results, pathology details, or comorbidities. Always consult a qualified oncologist or breast cancer specialist for personalized risk assessment and treatment planning.